ARTV
USDArtiva Biotherapeutics Inc. Common Stock
$1.800-0.200 (-10.000%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$2.000
High
$2.000
Low
$1.800
Volume
0.18M
Company Fundamentals
Market Cap
49.2M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.33M
Exchange
NGM
Currency
USD
52-Week Range
Low $1.78Current $1.800High $17.31
Related News
Analyst Upgrades
HC Wainwright & Co. Assumes Artiva Biotherapeutics at Buy, Announces Price Target of $12
HC Wainwright & Co. analyst Emily Bodnar assumes Artiva Biotherapeutics with a Buy rating and announces Price Target of $12.
View more
GlobeNewswire
Artiva Biotherapeutics to Participate in the Jefferies Global Healthcare Conference
SAN DIEGO, May 28, 2025 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (NASDAQ:ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell therapies for patients
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.